High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B

Untreated IT-phase patients with CHB had higher risks of HCC and death/transplantation than treated IA-phase patients. Unnecessary deaths could be prevented through earlier antiviral intervention in select IT-phase patients.